NVS - Novartis (NVS) CEO Vas Narasimham on Q3 2020 Results - Earnings Call Transcript
Novartis AG (NVS) Q3 2020 Earnings Conference Call October 27, 2020 9:00 am ET Company Participants Vas Narasimham - Chief Executive Officer Richard Sandor - Chief Executive Officer, Sandoz Marie-France Tschudin - President, Novartis Pharmaceuticals Susanne Schaffert - President, Novartis Oncology John Tsai - Head of Global Drug Development Harry Kirsch - Chief Financial Officer Samir Shah - Global Head of Investor Relations Conference Call Participants Mark Purcell - Morgan Stanley Graham Perry - Bank of America Andrew Baum - Citi Laura Sutcliffe - UBS Kerry Holford - Berenberg Peter Wellford - Jefferies Keyur Parekh - Goldman Sachs Simon Baker - Redburn Florent Cespedes - Societe Generale Richard Vosser - JP Morgan Richard Wagner - Wolfe Research Jo Walton - Credit Suisse Naresh Chouhan - Intron Health Richard Parkes - Exane BNP Presentation Operator Good morning and good afternoon, and welcome to the Novartis Q3 2020 results release conference call
For further details see:
Novartis (NVS) CEO, Vas Narasimham on Q3 2020 Results - Earnings Call Transcript